DENVER, May 24 /PRNewswire-FirstCall/ -- Wyndgate Technologies(R), a division of Global Med Technologies(R), Inc., announced today that it has signed an agreement with Adventist Lab Partners Blood Center to install Wyndgate’s SafeTrace(R) donor management system. Terms of the agreement were not disclosed.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO )
One of the deciding factors prompting Adventist Lab Partners Blood Center to choose Wyndgate’s system was the company’s ability to offer remote deployment through Hemo-Net. Hemo-Net is a Wyndgate business partner specializing in application service provider (ASP) solutions for blood management and transfusion services. With remote deployment, Adventist will be able to save the costs of purchasing and maintaining hardware and most third-party software. Through Hemo-Net, they will also gain continuous network monitoring, backup systems and disaster protection.
Cindy Wolfer, RN, HP(ASCP), Regional Clinical Nurse Supervisor of Adventist Lab Partners Blood Center, commented, “We chose the SafeTrace Donor Management System from Wyndgate Technologies and Hemo-Net because it offered many key elements that were a priority to us, such as minimal up front capital costs that met our budget, an excellently designed security system, dedicated support 24/7, proactive monitoring and maintaining of upgrades and installs. In addition to all of this, we were impressed by the company’s professionalism and the Wyndgate representatives’ business approach to help secure the purchase of the system in an efficient manner.”
“Adventist Lab Partners Blood Center is known for compassion and a commitment to quality care. We are honored that its blood bank team chose our SafeTrace donor management system to help them continue to serve their community,” stated Wm. Scott Dustin, Vice President of Sales and Marketing at Wyndgate. “Additionally, we are happy that our partnership with Hemo-Net will help this not-for-profit organization minimize expenses while still purchasing the system that Adventist Lab Partners Blood Center wanted the most. We are pleased to be involved in such a win-win situation.”
About Adventist Midwest Health System
Adventist Lab Partners Blood Center is affiliated with the Adventist Midwest Health System. Adventist Midwest Health is a not-for-profit Christian Health-care leader committed to partnering with physicians and community to provide whole-person care and promote wellness. Adventist Midwest Health includes Hinsdale, La Grange Memorial, and GlenOaks Hospitals, as well as Bolingbrook Medical Center and affiliated organizations. Through state-of-the-art technology, comprehensive medical services and wellness programs, 1,300 affiliated independent physicians and 5,000 employees touch hundreds of lives.
About Global Med Technologies, Inc.
Global Med Technologies, Inc. is an international e-Health, medical information technology company, providing information management software products and services to the healthcare industry. Its Wyndgate Technologies division is a leading supplier of information management systems to U.S. and international blood centers and hospital transfusion centers. Current clients of Wyndgate’s products and services manage more than 3 million units of blood, or over 22% of the U.S. blood supply, each year. Wyndgate’s products are being used in Canada and sub-Saharan Africa, and are being implemented in the Caribbean. Together, the SafeTrace Tx advanced transfusion management system and the SafeTrace(R) donor management system provide Vein-to-Vein(R) tracking from donor collection to patient transfusion.
For more information about Global Med’s products and services, please call 800-WYNDGATE or visit www.globalmedtech.com, www.peoplemed.com and www.wyndgate.com.
This news release may include statements that constitute forward-looking statements, usually containing the words “believe,” “estimate,” “project,” “expects” or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release.
* Patent Pending
Photo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comGlobal Med Technologies, Inc.
CONTACT: Michael I. Ruxin, M.D., of Global Med Technologies, Inc.,+1-303-238-2000; or Investor Relations, Paul Short, President of InvestmentStrategies, LLC, +1-304-523-3252, for Global Med Technologies, Inc.
